Proov is Featured in Forbes

Proov is Featured in Forbes

CEO and Founder Amy Beckley speaks with Forbes about the importance of progesterone in the fertility journey. 

Who better than a young, infertile, female scientist to come up with an OTC pharmacological test as first-line offense in early diagnosis of infertility? Enter now-39-year-old Amy Galliher-Beckley to blow all my theories out of the water- namely, that a biotech/genetics/pharma company can actually be founded in one's basement.”

Proov is the first at-home PdG - progesterone metabolite - test kit to confirm ovulation. Presence of progesterone means you have successfully ovulated, which is critical in trying to conceive. If PdG levels are negative and ovulation isn't successfully confirmed, it can lead to challenges when trying to conceive.  

“Beckley states that progesterone should stay elevated for at least 11 days, and 10 ng/ml minimum is thought to support pregnancy. Proov comes with seven testing sticks and directions. The tests will read either positive or negative.

Proov helps women understand their bodies better. Knowing your PdG levels, regardless of the result, can help women to feel more empowered about where they stand. Before paying thousands of dollars for alternative solutions like IVF, Proov is an easy to use tool that can help provide valuable insight into confirming healthy ovulation, which is the critical piece that makes all the difference when trying to conceive.

“As Beckley points out, the current protocol amongst Fertility physicians is to prescribe supplemental progesterone suppositories or injections after insemination attempts (and usually only for IVF patients). This is almost always after the fact of numerous unexplained and traumatic miscarriages. In Beckley's case, her luteal phase defect, combined with attrition in the thawing of embryos, was causing lots of unexplained miscarriages.”

Read the full article on Forbes. Have a question? Let’s talk.